Citadel Advisors - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,389,062
+204.6%
2,698,830
+123.7%
0.00%
+100.0%
Q2 2023$3,739,245
+153.4%
1,206,208
+13.6%
0.00%
Q1 2023$1,475,350
+2.0%
1,061,403
+46.0%
0.00%
Q4 2022$1,446,440
-58.0%
726,854
-57.3%
0.00%
-100.0%
Q3 2022$3,441,000
-27.5%
1,702,793
+14.1%
0.00%0.0%
Q2 2022$4,746,000
-27.6%
1,492,290
-5.1%
0.00%0.0%
Q1 2022$6,558,000
-19.4%
1,572,620
-7.4%
0.00%
-50.0%
Q4 2021$8,137,000
+22.6%
1,698,647
+36.6%
0.00%
+100.0%
Q3 2021$6,639,000
+87.9%
1,243,307
+80.2%
0.00%0.0%
Q2 2021$3,533,000
-19.2%
690,038
+6.1%
0.00%0.0%
Q1 2021$4,375,000
-39.1%
650,115
-58.7%
0.00%
-50.0%
Q4 2020$7,186,000
+36.3%
1,572,424
+15.7%
0.00%
+100.0%
Q3 2020$5,272,000
+60.2%
1,358,727
+96.5%
0.00%0.0%
Q2 2020$3,291,000
+136.1%
691,313
+72.6%
0.00%0.0%
Q1 2020$1,394,000
-39.5%
400,476
-16.2%
0.00%0.0%
Q4 2019$2,303,000
+15.9%
477,910
-30.2%
0.00%0.0%
Q3 2019$1,987,000
-54.4%
684,955
+12.6%
0.00%
-50.0%
Q2 2019$4,361,000
+2270.1%
608,251
+4578.9%
0.00%
Q1 2019$184,000
-21.0%
13,000
+23.8%
0.00%
Q3 2018$233,000
-97.7%
10,500
-98.3%
0.00%
-100.0%
Q2 2018$9,922,000604,6340.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$103,087,0005.89%
Eversept Partners, LP 6,440,572$30,850,3401.97%
TPG GP A, LLC 16,213,367$77,662,0000.78%
Signature Wealth Management Partners, LLC 87,666$420,0000.36%
Hedges Asset Management LLC 75,000$359,0000.28%
Hillsdale Investment Management Inc. 869,916$4,167,0000.28%
Tranquilli Financial Advisor LLC 71,414$342,0000.24%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$862,0000.19%
GLOBEFLEX CAPITAL L P 297,414$1,424,0000.15%
XTX Topco Ltd 23,742$114,0000.06%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders